The regioselective enolization of 4-oxo- N -(9-phenylfluoren-9-yl)proline benzyl ester ( 5 ) followed by alkylation with different alkyl halides has been used to synthesize a variety of β-alkylproline derivatives. In particular, enolization of 5 with 400 mol % of KN(SiMe 3 ) 2 and alkylation with iodomethane provided 3,3-dimethyl-4-oxo- N -(9-phenylfluoren-9-yl)proline benzyl ester ( 7a ) in excellent yield. Subsequent hydride reduction of ketone 7a and protecting group exchange by hydrogenation in the presence of di- tert -butyl dicarbonate provided enantiopure (2 S,4R )- and (2 S,4S )-3,3-dimethyl-4-hydroxy- N -(BOC)prolines 2 . Hydroxyproline−valine chimeras (2 S,4R )- and (2 S,4 S )- 2 are each synthesized from hydroxyproline in six steps and 27% respective overall yield. Deoxygenation of 3,3-dimethyl-4-hydroxy- N -(9-phenylfluoren-9-yl)proline benzyl esters 9 via their conversion to xanthates 10 followed by tributylstannane-mediated reduction provided 3,3-dimethyl- N -(9-phenylfluoren-9-yl)proline benzyl ester ( 11 ) in excellent yield. Hydrogenation of 11 with Pearlman's catalyst in the presence of di- tert -butyl dicarbonate then furnished (2 S )-3,3-dimethyl- N -(BOC)proline ( 1 ) in the last step of an eight-step synthesis (41% overall yield) from hydroxyproline. Both proline−valine and hydroxyproline−valine chimeras 1 and 2 were designed to serve as tools for studying the conformational requirements of biologically active peptides.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: